By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
Overview
Focuses on how pulmonary hypertension (PH) may involve multiple clinical conditions and pose complications for the majority of cardiovascular and respiratory diseases. The guideline was developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). The guideline is endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG).
Members Only Content
Join APTA to get unlimited access to content including evidence-based research, guidance on payment changes, and other resources to help you thrive. Learn more about membership benefits.
Already a member? Log in
Date: October 7, 2022
Contact: practice@apta.org
Content Type: CPG
Galiè N, Humbert M, Vachiery JL, et al; European Society of Cardiology, European Respiratory Society
You Might Also Like...
CPG
Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice GuidelinesAug 29, 2023
This updated guideline provides an evidenced-based and patient-centered approach to management of patients with chronic coronary disease.
CPG
Canadian Cardiovascular Society 2021 Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the AdultMar 26, 2021
Contains updated findings and recommendations including the use of non-fasting lipid determination as a suitable alternative to fasting levels.
CPG
Acute Coronary Syndromes [NICE NG185]Nov 18, 2020
Recommendations on how to improve survival and quality of life for people who have a heart attack or unstable angina.